Quartz
US · 29 mins ago
FDA approves Revolution Medicines' first targeted drug for advanced pancreatic cancer
The drug, Rasonque, nearly doubled median overall survival compared with standard chemotherapy in a 500-patient trial
Do you trust Quartz?
Sign in to rate
Discussion
?
No comments yet — be the first to start the discussion!